Development of animal models against emerging coronaviruses: From SARS to MERS coronavirus

Troy C Sutton1, Kanta Subbarao1

  • 1Laboratory of Infectious Disease, NIAID, NIH, United States.

Virology
|March 21, 2015
PubMed

Insights

Developing animal models for Middle East respiratory syndrome coronavirus (MERS-CoV) is crucial for evaluating countermeasures. Most lab animals are resistant to MERS-CoV due to receptor differences, unlike SARS-CoV.

Area of Science:

  • Virology
  • Infectious Diseases
  • Public Health

Background:

  • Two novel coronaviruses, SARS-CoV and MERS-CoV, have caused severe human disease.
  • While bats are a reservoir, SARS-CoV spread via civets and MERS-CoV via camels.
  • MERS-CoV remains an ongoing public health threat due to continued introductions.

Purpose of the Study:

  • To describe animal models for studying coronaviruses.
  • To focus on host-range restriction at the viral receptor level.
  • To discuss approaches for developing a MERS-CoV countermeasure evaluation model.

Main Methods:

  • Review of existing animal models for coronavirus studies.
  • Analysis of MERS-CoV host-range restriction mechanisms.
  • Discussion of strategies for MERS-CoV model development.

Main Results:

  • Most laboratory animals are refractory or semi-permissive to MERS-CoV infection.
  • Host-range restriction is primarily due to MERS-CoV receptor sequence heterogeneity.
  • Unlike SARS-CoV, few animal species are permissive to MERS-CoV.

Conclusions:

  • Effective animal models are essential for developing MERS-CoV countermeasures.
  • Understanding viral receptor interactions is key to overcoming host-range restrictions.
  • Further development of MERS-CoV models is needed for public health preparedness.

Related Concept Videos